Menu

Evogene Ltd. EVGN

Full chart Compare
Set alert

Price alert · EVGN

All alert types
0.27 USD -0.05 (-15.73%)

At closeNov 6, 2026, 6:21 PM EST

0.25 -0.02 -7.71%

After hours · Nov 6, 6:21 PM ET

0.2503 Day range 0.282
0.2503 52-week range 1.28
YTD
-75.36%
1 year
-76.64%

Revenue & Expenses

Other Income → Expenses: $5.38MExpenses → Gross Loss: $591.00KExpenses → Selling, General & Admin: $5.38MExpenses → Research & Development: $6.26MExpenses → Interest Expense: $1.84MExpenses → Income Tax: $1.00KOther Operating Income → Expenses: $205.00KNet Loss → Expenses: $8.48MRevenue → Cost of Revenue: $3.50MOther Income$5.38MOther Operating Income$205.00KNet Loss$8.48MCost of Revenue$4.09MExpenses$14.07MGross Loss$591.00KSelling, General & Admin$5.38MResearch & Development$6.26MInterest Expense$1.84MIncome Tax$1.00KRevenue$3.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EVGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.50M5.58M2.98M1.68M930.00K
-591.00K3.20M1.49M766.00K163.00K
-12.03M-18.80M-22.23M-26.94M-30.95M
-8.48M-16.48M-23.88M-26.64M-27.79M
-1.08-2.90-5.20-6.44-6.90
EVGN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.99M15.31M20.77M28.98M32.33M
20.05M39.86M51.10M56.13M76.30M
8.07M25.03M22.42M21.34M12.88M
2.20M12.87M11.51M11.93M2.67M
-82.00K-1.45M12.05M27.93M53.65M
EVGN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-13.50M-19.70M-21.58M-23.68M-24.72M
17.74M9.62M-4.54M13.27M-20.57M
-6.60M4.66M18.15M9.34M30.28M
-121.00K-616.00K-551.00K-1.17M-847.00K
-2.35M-5.47M-8.21M-3.35M-13.90M